PPA
AVEO

Parametric Portfolio Associates’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Parametric Portfolio Associates’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,005
Closed -$328K – 3827
2014
Q1 		$328K Buy
22,005
+6,684
+44% +$120K ﹤0.01% 3397
2013
Q4 		$280K Sell
15,321
-1,850
-11% -$37K ﹤0.01% 3464
2013
Q3 		$354K Buy
17,171
+9,807
+133% +$225K ﹤0.01% 3300
2013
Q2 		$184K Buy
+7,364
New +$315K ﹤0.01% 3487

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Parametric Portfolio Associates's AVEO Position: Q2 2014 in Review

Parametric Portfolio Associates sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2014, closing a stake of 22,005 shares — an estimated $328K sold.

Parametric Portfolio Associates first reported a position in AVEO in Q2 2013 and held it in 4 quarters. The position peaked at $354K in Q3 2013. 61 funds tracked by Wall St. Rank hold AVEO as of Q2 2014.

  • Parametric Portfolio Associates reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Parametric Portfolio Associates sold 22,005 AVEO Pharmaceuticals, Inc. shares in Q2 2014, an estimated $328K.
  • Parametric Portfolio Associates first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Parametric Portfolio Associates's AVEO Pharmaceuticals, Inc. position peaked at $354K in Q3 2013.
  • 61 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2014.

Based on Parametric Portfolio Associates's 13F filing for Q2 2014, filed 12 Aug 2014.